Both in Lab Analytical Instruments
Pacific Biosciences of California vs Cytek Biosciences
Over the past year PACB returned +85.2% and CTKB returned +71.8%; their daily moves had a correlation of 0.38.
PACB +85.2% CTKB +71.8%Growth of $1, one year, split-adjusted
| Metric | PACB | CTKB |
|---|---|---|
| Price | $2.37 | $5.96 |
| Market cap | $736.7M | $774.7M |
| Today | +29.51% | +3.47% |
| 1 month | +74.9% | +24.7% |
| 6 months | +79.5% | +36.4% |
| Year to date | +26.7% | +18.0% |
| 1 year | +89.6% | +76.3% |
| Revenue growth (YoY) | −1.9% | +5.6% |
| Gross margin | 32.4% | 58.9% |
| Net margin | −114.7% | −25.3% |
| P/E (TTM) | — | — |
| Price / sales | 4.6× | 3.7× |
| Net cash | -$407.5M | $261.8M |
| Dividend yield | — | — |
| Volatility (60d) | 97.2% | 44.7% |
| Short % of float | 19.6% | 4.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).